Roivant Sciences Director Melissa Epperly Files Form 144 to Sell $930K in Common Stock

Overview

On September 15, 2026, Melissa Epperly, a Director at Roivant Sciences Ltd. ($ROIV), submitted a Form 144 notice proposing the sale of 22,688 shares of common stock with an aggregate market value of approximately $930,661.76 (implied price of ~$41.02 per share).

Transaction Details

• Securities to be Sold: 22,688 common shares.
  • 17,750 shares to be acquired through the exercise of stock options on September 15, 2026.
  • 4,938 shares acquired via restricted stock units on September 10, 2026.
• Trading Plan: The proposed sale is executed pursuant to a Rule 10b5-1 trading plan adopted on March 30, 2026.
• Broker: Morgan Stanley Smith Barney LLC Executive Financial Services.
• Past 3 Months Activity: The filer previously sold 17,750 shares on June 29, 2026, generating gross proceeds of $610,188.20 under a 10b5-1 plan.

Impact Analysis

The proposed transaction represents a minuscule percentage (<0.01%) of Roivant Sciences Ltd.'s 722,323,015 shares outstanding. Given that this sale is pre-scheduled under a standard Rule 10b5-1 trading plan and consists primarily of option exercises and RSU vesting, its market significance is rated Low.